Vivien Jiaqian Zhu | Humanities | Best Researcher Award

Dr. Vivien Jiaqian Zhu | Humanities | Best Researcher Award

PhD at Stanford University and University of California, Berkeley, United States.

Vivien Jiaqian Zhu is a Ph.D. candidate at UC Berkeley and a visiting scholar at Stanford University, specializing in Japanese literature and art history. She has a diverse academic background, with studies spanning multiple prestigious institutions such as Harvard, Stanford, and Cambridge. Zhu’s research primarily focuses on East Asian languages and cultures, particularly on topics related to Japanese literature, art history, and the intersection of textuality and haptic aesthetics. She has demonstrated excellence through various honors, fellowships, and academic experiences, including her dissertation on the haptic beauty in Kawabata Yasunari’s works. Zhu has also presented at numerous international conferences and contributed significantly to the field through archival research, publications, and curatorial work.

Publication Profile

Orcid

Education 🎓

Vivien Jiaqian Zhu has pursued a diverse academic path across prestigious institutions. She is currently a Ph.D. candidate in Japanese Language and Literature at UC Berkeley, where she also received the Regent’s Fellowship. Her Master’s thesis focuses on Kawabata Yasunari’s works, exploring the tactile beauty in his Palm-of-the-Hand Stories. Zhu’s undergraduate studies at UC Berkeley culminated in an honors degree in Comparative Literature and Chinese Language, with a minor in the History of Art. She earned Phi Beta Kappa and other honors during her time at Berkeley. Zhu also studied advanced Japanese at the Inter-University Center for Japanese Language Studies in Yokohama and undertook language programs at Sophia University, Japan. Her academic pursuits also took her to Middlebury College and the Culinary Institute of America. At present, she is also studying Early Modern Japanese Palaeography at the University of Cambridge under the Mitsubishi Research Fellowship.

Experience 🩺

Vivien Jiaqian Zhu has accumulated extensive experience through her academic and professional roles. She is a visiting scholar at Stanford University, where she collaborates on research projects and participates in academic seminars. Zhu has also worked as a graduate student researcher at UC Berkeley, where she assisted in archival research and curated collections, focusing on Japanese literature and East Asian cultures. Her professional experience extends to editorial roles, including serving on the editorial board of the International Journal of Sustainable Fashion & Textile and as the editor of the Language & Theory section of Ling Mag. Zhu’s expertise is also reflected in her involvement in the International Joint Digital Center for Japanese Art and Culture at Ritsumeikan University. She has conducted research across various international libraries, including UC Berkeley, Nanjing University, and the University of Tokyo. Additionally, Zhu has gained teaching experience, particularly in Chinese calligraphy and East Asian studies.

Awards and Honors 🏅

Vivien Jiaqian Zhu’s academic excellence has been recognized through numerous prestigious awards and fellowships. In 2024, she received the Mitsubishi Research Fellowship for Early Modern Japanese Palaeography at the University of Cambridge, allowing her to study under the Emmanuel College at the university. Zhu has been honored with the Regent’s Fellowship for Graduate Study at UC Berkeley, nominated by Professor H. Mack Horton. She was awarded the CJS Graduate Student Fellowship, the UC Berkeley Departmental Award, and the Theresa Hak Kyung Cha Fellowship Award. Zhu’s academic recognition extends to memberships in Phi Beta Kappa and Golden Key International Honor Society. She has also earned multiple scholarships and fellowships, including the Nippon Foundation Fellowship for Japanese language studies at Stanford, the Dietrich von Bothmer Classical Scholarship, and the Institute of International Studies Undergraduate Merit Scholarship. Her research contributions have been consistently acknowledged, making her a prominent figure in East Asian literary studies.

Research Focus 🔬

Vivien Jiaqian Zhu’s research focuses on the intersection of Japanese literature, art history, and East Asian cultural studies. Her doctoral research at UC Berkeley explores the tactile and haptic elements in Kawabata Yasunari’s Palm-of-the-Hand Stories, examining how sensory experiences influence narrative structure and reader engagement. Zhu’s academic interests include the cultural and historical contexts of Japanese literature, with a particular emphasis on modern and early modern periods. She investigates the transnational connections between Japan, China, and the broader East Asian region, often incorporating interdisciplinary methodologies from comparative literature, art history, and cultural studies. Additionally, Zhu has worked on archival research projects, including studies of Chinese calligraphy, criminal law, and comparative law. Her studies in early modern Japanese palaeography and her deep engagement with East Asian art and literature reflect her broad intellectual interests, positioning her as a key scholar in understanding the intricate relationships between language, culture, and history in the region.

Conclusion

Vivien Jiaqian Zhu is an exceptionally talented researcher whose interdisciplinary approach and scholarly achievements make her an outstanding candidate for the Best Researcher Award. Her unique focus on the tactile aesthetics in Japanese literature and art, along with her academic excellence, make her stand out as a leader in her field. With a proven track record of global recognition and a commitment to advancing knowledge, Zhu’s continued contributions will undoubtedly have a lasting impact on the study of East Asian literature and art history.

Publication Top Notes 📚

  • “I Dwell in Possibility”: The Poetics of Space in the Works of 1980s Japanese Avant-Garde Fashion DesignersComparative Literature: East & West

    2024-12-08 | journal-article

    Source:Crossref

    DOI: 10.1080/25723618.2024.2433301

 

Hawraa Shbeeb | Medicine | Best Researcher Award

Dr. Hawraa Shbeeb | Medicine | Best Researcher Award

Fellowship in Infertility and IVF at Tehran University of Medical Sciences, Iran, Iran.

Dr. Hawraa Shbeeb is a dedicated Obstetrics and Gynecology Specialist currently pursuing a Fellowship in Infertility and IVF at Tehran University of Medical Sciences. She has significant international experience, registered as a specialist in both Iran and Lebanon, and is affiliated with several esteemed organizations like the Lebanese Society of Obstetrics and Gynecology (LSOG) and ISUGO. Her certifications demonstrate a commitment to continuous medical education, and she has contributed to research in infertility and reproductive health, with a recent publication in a peer-reviewed journal.

Publication Profile

Orcid

Education 🎓

Dr. Hawraa Shbeeb earned her Doctor of Medicine (MD) degree from Mashhad University of Medical Sciences (2009-2017). She specialized in Obstetrics and Gynecology at the same institution, completing her residency in December 2021. Currently, she is advancing her expertise through a Fellowship in Infertility and IVF at the prestigious Tehran University of Medical Sciences (2023-present). Her educational background also includes passing the Lebanese Colloquium Medicine Exam (2022), enabling her to practice in Lebanon. Her academic journey reflects a strong focus on women’s reproductive health, with an emphasis on infertility, assisted reproductive technologies, and high-risk pregnancies. Dr. Shbeeb’s pursuit of advanced certifications and continuous learning underscores her dedication to providing cutting-edge care in the field of reproductive medicine.

Experience 🩺

Dr. Hawraa Shbeeb has extensive experience as an Obstetrics and Gynecology Specialist. She has been practicing at the Imam Khomeini Hospital Complex in Tehran since January 2023. Previously, she served at the Imam Reza Hospital and Ghaem and Ommolbanin Hospitals in Mashhad, Iran (2017-2020). Dr. Shbeeb is also registered with the Lebanese Order of Physicians (LOP) and has been an active specialist in Lebanon since October 2022. Her affiliations with professional organizations like LSOG and ISUGO highlight her involvement in the global medical community. Additionally, she is a dedicated volunteer with the Iranian Red Crescent (2024-present), contributing to humanitarian efforts. Her experience spans clinical practice, research, and teaching, demonstrating a holistic approach to women’s healthcare.

Awards and Honors 🏅

Dr. Hawraa Shbeeb has earned multiple accolades for her contributions to healthcare and continuous education. She received the International Volunteer Day Award from the Iranian Red Crescent for her humanitarian work in Khorasan Razavi. Her certifications from esteemed bodies like ACOG, SAFOG, FOGSI, and the American Association for Continuous Education reflect her commitment to excellence in gynecology and reproductive health. Notable certifications include those in Minimal Access Surgery, Infertility & ARTs, Pregnancy Complications, and Fetal Medicine. She also holds certifications in Advanced Cardiac Life Support (ACLS), Pediatric Advanced Life Support (PALS), and Basic Life Support (BLS) from Medtigo Health Education. These honors underscore her dedication to patient care, continuous learning, and professional excellence.

Research Focus 🔬

Dr. Hawraa Shbeeb’s research focuses on the fields of infertility, assisted reproductive technology (ART), and high-risk pregnancies. Her work addresses rare and complex gynecological cases, particularly those involving ectopic pregnancies and complications arising from embryo transfer procedures. Through her recent fellowship, she delves into advanced infertility treatments, IVF protocols, and improving outcomes for couples facing reproductive challenges. Dr. Shbeeb is dedicated to exploring new frontiers in minimal-access gynecological surgery, fetal medicine, and pregnancy complications. Her goal is to bridge clinical practice and research to enhance patient care. Her published case report on cornual pregnancy highlights her commitment to identifying and addressing rare medical conditions, providing valuable insights to the medical community.

Conclusion

Dr. Hawraa Shbeeb is a strong candidate for the Best Researcher Award due to her extensive clinical expertise, dedication to infertility research, and international professional affiliations. Her recent publication and ongoing fellowship in IVF indicate active engagement with cutting-edge reproductive medicine. Strengthening her research output and focusing on collaborative projects can further solidify her standing as a distinguished researcher in her field.

Publication Top Notes 📚

  • Title: Cornual Pregnancy as a Rare Entity of Ectopic Pregnancy After Assisted Reproductive Therapy‐Embryo Transfer (ART‐ET): A Case ReportPublication: Clinical Case Reports
    Year: 2024
    ISSN: 2050-0904Authors: Hawraa Hassan Shbeeb

 

 

Xiaoning wang | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Xiaoning wang | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Xiaoning wang, Department of Hematology, The First Affiliated Hospital of Xi’an Jiaotong University, China

Dr. Xiaoning Wang serves as the Deputy Director at The First Affiliated Hospital of Xi’an Jiaotong University. With over 17 years of medical expertise, Dr. Wang is an Associate Chief Physician specializing in hematopoietic stem cell transplantation and immunotherapy. 🧬✨ He has led notable research projects, including advancements in acute T-cell leukemia treatment and NK cell reconstruction. Dr. Wang has published extensively in renowned journals like Blood and Nature Communications 🩸📚 and holds multiple patents. A leader in the field, he is a key figure in various medical associations, driving innovation and collaboration in hematology. 🌐🎓

 

Publication Profile

Orcid

Academic and Professional Background 🎓💼

Assoc. Prof. Dr. Xiaoning Wang has a rich medical career spanning over 17 years. He currently serves as an Associate Chief Physician (Jan 2017 – Present), where he oversees advanced hematology treatments and research. Previously, he worked as an Attending Physician (Mar 2012 – Dec 2016), gaining extensive expertise in patient care and clinical decision-making. His medical journey began as a Resident Doctor (July 2006 – Feb 2012), where he honed his foundational skills in diagnostics and treatment. Dr. Wang’s professional growth reflects his dedication to medical excellence and patient-focused innovation. 🏥🩺✨

 

Research Contributions

Assoc. Prof. Dr. Xiaoning Wang is a prominent researcher whose work spans hematology, oncology, and infectious diseases. Key studies include identifying the novel HLA-C*14:02:01:33 allele via advanced sequencing techniques, optimizing treatment regimens for severe pneumocystis pneumonia, and investigating high NK cell levels in grafts reducing febrile neutropenia post-transplantation. Her pivotal work on molecular biomarkers in multiple myeloma and graft-versus-host disease therapies showcases her innovative approach to immunology and stem cell research. Dr. Wang has significantly contributed to international medical knowledge, with publications in Nature Communications, Blood, and JAMA Ophthalmology. 📚✨

Publication Top Notes 📚

  • The novel HLA-C*14:02:01:33 allele identified by Pacific Biosciences HiFi sequencing in a Chinese individual.
  • A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
  • Endogenous Aspergillus thermomutatus Endophthalmitis in a Patient With Myelodysplastic Syndrome.
  • High levels of NK Cells in graft are associated with reduced febrile neutropenia after haploidentical peripheral blood stem cell transplantation.
  • The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients.
  • Bloody tears as initial manifestation of rhino-orbital mucormycosis.
  • Pneumocystis jiroveci Pneumonia secondary to tyrosine kinase inhibitor with blinatumomab therapy: A case report.
  • ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
  • Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils Novel Prognostic Biomarkers in Multiple Myeloma.
  • Acute myeloid leukemia secondary to acute B lymphoblastic leukemia treated with maintenance therapy in a child: A case report.
  • Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis.

 

Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Prof Dr. Pedro Antonio Regidor | Medicine and Dentistry | Best Innovation Award

Prof Dr. Pedro Antonio Regidor, Exeltis, Germany

Born on January 5, 1964, in Madrid, Spain, Prof. Dr. Pedro Antonio Regidor holds dual German and Spanish citizenship. He completed his medical studies at the University of Essen and gained extensive experience in gynecology and obstetrics across Germany and Venezuela. Notably, he served as Medical Director at Exeltis Europe and Global Projects. His qualifications include specialized certifications in radiological diagnostics and gynecological endocrinology. Prof. Dr. Regidor is recognized for his contributions to women’s health and medical innovation. Currently, he continues his work as a Medical Director and private practitioner in Munich, Germany. 🌍💉

Publication profile

Scopus

Professional Background

Prof. Dr. Pedro Antonio Regidor, born on January 5, 1964, in Madrid, Spain, and holding both German and Spanish citizenship, has a distinguished career in the field of gynecology and obstetrics. His educational journey began at the Deutsche Schule Madrid and continued with medical studies at the University of Essen, where he completed his state exams and medical training. His professional experience spans multiple countries and prestigious institutions, including roles as a senior physician and medical director at prominent medical centers in Germany.

Innovative Contributions

Prof. Dr. Regidor has demonstrated a commitment to advancing medical practice and patient care. His roles in various high-profile positions, including Medical Director at Exeltis Europe & Global Projects, reflect his leadership in implementing innovative practices and advancing healthcare delivery. His experience with cutting-edge medical technologies and practices, including his certifications in advanced diagnostic and therapeutic techniques, underscores his contributions to medical innovation.

Awards and Recognitions

Prof. Dr. Regidor’s career is marked by several significant recognitions, including his certifications in specialized fields such as radiological diagnostics and gynecological endocrinology. His role as a Medical Director involved overseeing global projects, indicating a strong track record of managing and implementing innovative solutions across diverse healthcare settings.

Publication Top Notes

  • “The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users’ acceptability and newborn development” (Gynecological Endocrinology, 2024) 📅
  • “OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF A NEW VAGINAL PESSARY CONTAINING 300MG TINIDAZOLE, 200MG TIOCONAZOLE AND 100MG LIDOCAINE” (Reproductive Endocrinology, 2024) 📅
  • “Nausea and Vomiting of Pregnancy and its Management with the Dual-Release Formulation of Doxylamine and Pyridoxine” (Geburtshilfe und Frauenheilkunde, 2023) 📅
  • “Improvement in menopausal symptoms with a nutritional product containing evening primrose oil, hop extract, saffron, tryptophan, vitamins B6, D3, K2, B12, and B9” (European Review for Medical and Pharmacological Sciences, 2023) 📅
  • “10-month retrospective study on compliance and tolerability of the drospirenone-only pill” (European Review for Medical and Pharmacological Sciences, 2023) 📅
  • “Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature” (Journal of Obstetrics and Gynaecology, 2023) 📅
  • “Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen” (Women’s Health, 2023) 📅
  • “The drospirenone (DRSP)-only pill: clinical implications in the daily use” (European Journal of Contraception and Reproductive Health Care, 2023) 📅
  • “Erratum: Oral Progestins in Hormonal Contraception: Importance and Future Perspectives of a New Progestin Only-Pill Containing 4 mg Drospirenone” (Geburtshilfe und Frauenheilkunde, 2022) 📅
  • “Evaluation of the food effect on a drospirenone only contraceptive containing 4 mg administered with and without high-fat breakfast in a randomised trial” (BMC Women’s Health, 2022) 📅


Conclusion

Prof. Dr. Pedro Antonio Regidor’s extensive experience in gynecology, his leadership in implementing innovative healthcare practices, and his significant contributions to medical advancements, he is a strong candidate for the “Research for Best Innovation Award.” His career reflects a profound impact on medical practices and innovation, aligning well with the award’s criteria.

 

 

 

 

 

 

 

 

Shuo Sha | Hypertension | Best Researcher Award

Dr. Shuo Sha | Hypertension | Best Researcher Award

Dr. Shuo Sha, The First Hospital of Shanxi Medical University, China

Dr. Sha Shuo is a dedicated PhD candidate at Shanxi Medical University, specializing in Internal Medicine. She began her academic journey in August 2023 and is expected to graduate by June 2027. With a commitment to full-time study, Dr. Sha exemplifies perseverance and academic excellence in her pursuit of higher education. Her research focuses on advancing knowledge in the field of Internal Medicine, aiming to contribute significantly to healthcare innovation. 🎓

 

Publication profile

Scopus

🎓 Education

Sha Shuo is currently pursuing her PhD in Internal Medicine at Shanxi Medical University. She joined the graduate school in August 2023 under a full-time format and is expected to graduate by June 2027.

Research Focus

Dr. Sha Shuo’s research focuses on energy-efficient automatic train operation for high-speed railways, with a particular emphasis on discrete notches and neutral sections. She investigates how these elements impact overall energy consumption and operational efficiency. By studying these factors, Dr. Sha aims to optimize train performance and energy usage, contributing to sustainable transportation solutions 🚄. Her work integrates theoretical models with practical applications, aiming to enhance the reliability and environmental sustainability of high-speed rail networks through innovative operational strategies and technological advancements in railway systems.

 

Publication Top Notes

Energy-efficient automatic train operation for high-speed railways: Considering discrete notches and neutral sections

Tang Gao | Medicine and Dentistry | Best Researcher Award

Dr. Tang Gao | Medicine and Dentistry | Best Researcher Award

Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, China

Dr. Tang Gao, renowned for groundbreaking research in Medicine and Dentistry, has been honored with the prestigious Best Researcher Award. His exceptional contributions at Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, China, have significantly advanced healthcare knowledge and patient care. 🏆 Dr. Gao’s dedication to pioneering research not only inspires his peers but also enhances medical practices worldwide, setting a benchmark for excellence in academia and healthcare innovation.

Profile

Google Scholar

Education

Dr. Tang Gao is a dedicated professional with a strong academic background in medicine. He graduated from Hubei University of Chinese Medicine with a Bachelor’s degree in pharmacy in 2013, followed by a Master of Medicine from Central South University in 2016, and a Doctorate in Medicine in 2019. His journey reflects a deep commitment to advancing medical knowledge and expertise. 🎓 Dr. Gao’s academic pursuits have equipped him with a comprehensive understanding of pharmaceutical sciences and clinical practice, positioning him well to contribute significantly to the field of medicine.

Research and work experience

Dr. Tang Gao completed his post-doctoral work at Union Hospital, Tongji Medical College of HUST from October 2019 to June 2022. Since July 2022, he has served as an Assistant Professor at the same institution. His research focuses on [mention specific research interests if known]. With a commitment to advancing medical knowledge and education, Dr. Gao brings a wealth of experience and dedication to his role. 🎓 His contributions to academia and healthcare underscore his passion for bridging theory with practical application in medicine.

Projects

Dr. Tang Gao has secured several research grants to advance medical diagnostics and treatment modalities, focusing notably on heart transplant rejection and infectious disease detection. 🌟 His projects include developing activatable bionic probes targeting macrophages for early heart transplant rejection diagnosis, utilizing smart fluorescence/photoacoustic molecular probes for acute rejection diagnosis, and innovating rapid SARS-CoV-2 antibody detection methods. These efforts are supported by various foundations and institutions, highlighting his contributions to both clinical and research fields. Dr. Gao’s work underscores a commitment to integrating advanced biomedical technologies for improving patient outcomes and healthcare efficacy. 🧬

Academic awards

Dr. Tang Gao has achieved remarkable recognition in the field of medicine, notably earning accolades such as the Outstanding Doctoral Dissertation of Hunan Province and being named among the Outstanding Graduates of the region. His contributions to natural science have been acknowledged with the Second Prize of the Natural Science Award of Hunan Province. Additionally, he has been honored with the Chinese Medical Association Youth Science and Technology Award, highlighting his dedication and innovation in medical research and practice. 🌟 Dr. Gao’s accomplishments underscore his commitment to advancing healthcare and scientific knowledge.

Publications Top Notes

 

Erica Pietroluongo | Medicine | Young Scientist Award

Dr. Erica Pietroluongo | Medicine | Young Scientist Award

Dr. Erica Pietroluongo, University of Naples Federico II, Italy

👩‍⚕️ Dr. Erica Pietroluongo is a dedicated oncologist and researcher based in Naples, Italy. With an MD from the University of Naples Federico II and ongoing PhD studies in Advanced Biomedical and Surgical Therapies, she specializes in medical oncology, particularly in rare tumors. Dr. Pietroluongo is actively involved in various professional societies, including the American Society of Clinical Oncology and the International Thymic Malignancy Working Group. Her research focuses on improving treatment personalization in breast cancer and investigating bioumoral determinants in SARS-Cov-2-infected patients with thymic epithelial tumors. She also contributes to teaching and training future medical professionals.

Publication Profile:

Scopus

Orcid

Education:

📚 Dr. Erica Pietroluongo pursued her passion for medicine at the University of Naples Federico II, where she earned her MD in Medicine. With a strong foundation in healthcare, she embarked on a journey of continuous learning, currently immersing herself in the realm of research as a PhD student in Advanced Biomedical and Surgical Therapies. Under the guidance of Prof. F Pane at the Department of Clinical Medicine and Surgery, University of Naples Federico II, she delves into cutting-edge studies. 🎓 Committed to advancing medical knowledge, Dr. Pietroluongo’s dual roles as a physician and researcher epitomize her dedication to enhancing patient care and outcomes.

Teaching and Training:

📝 Dr. Erica Pietroluongo is deeply committed to advancing her skills in clinical research and teaching methodologies. In April 2023, she participated in a Medical Writing Course organized by the Italian Society of Surgery in Campobasso, in collaboration with prestigious institutions like Springer Nature and the University of Naples Federico II. This course equipped her with essential writing skills vital for disseminating research findings effectively. Moreover, in June 2023, she further honed her expertise as an “Expert in Evaluation and Facilitation of Regional Oncology Networks” through a program facilitated by AGENAS, the National Agency for Health Regional Services. 🌟 These training initiatives underscore Dr. Pietroluongo’s commitment to enhancing her capabilities and contributing to the advancement of healthcare practices.

Research Focus:

🔍 Dr. Erica Pietroluongo’s research focus primarily revolves around two key areas: thymic epithelial tumors and breast cancer. In her studies on thymic epithelial tumors, she explores the impact of SARS-Cov-2 mRNA vaccines on patients’ immune responses and seroconversion. Additionally, she investigates the potential diagnostic role of miRNAs in breast cancer, particularly miRNA-27a and miRNA-128, packaged in extracellular vesicles. Her work not only sheds light on the immunological responses to COVID-19 vaccines in cancer patients but also aims to identify novel biomarkers for improved diagnosis and prognosis in breast cancer. Dr. Pietroluongo’s research contributes significantly to both oncology and immunology fields. 🎯

Publication Top Notes: